Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06863675

Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study]

Status
Not Yet Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Singapore National Eye Centre · Other Government
Sex
All
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Assess the effect and changes of eye misalignment (strabismus) with myopia control glasses Assess the efficacy of myopia control glasses on childhood myopia progression in children with strabismus due to the uncertainty clinicians face when prescribing myopia control glasses to these strabismic children

Detailed description

Studies have been done to show that spectacles, atropine eye drops, and outdoor activities have some efficacy in slowing myopia progression in children, however most of such studies exclude children with significant eye conditions such as strabismus or nystagmus to isolate the effects of myopia control treatment. In this study, we would like to investigate whether these specialized glasses can effectively slow down the progression of myopia in children with strabismus. Since strabismus can affect visual development, this study would also be able to assess the effect and changes of eye misalignment (strabismus) with myopia control glasses. The study also aims to assess the efficacy of myopia control glasses on childhood myopia progression in children with strabismus due to the uncertainty clinicians face when prescribing myopia control glasses to these strabismic children.

Conditions

Interventions

TypeNameDescription
DEVICEHAL lenses for children with strabismusIt has been shown that peripheral segmented defocus spectacles can slow myopia progression. The Essilor® Stellest™ lens has been designed with an exclusive and pioneering technology called HALT (Highly Aspherical Lenslet Target). The HALT technology is made of a constellation of 1,021 invisible lenslets. This constellation creates a signal in front of the retina that acts as a shield against eye elongation and, therefore, myopia progression. Studies suggest that children are tolerable against these glasses, and the lenses can slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day. It can be considered as one of the best available myopia control spectacle lens designs, being superior to progressive addition and bifocal lenses.
DEVICESVL for children with strabismusSVL for children with strabismus

Timeline

Start date
2025-06-01
Primary completion
2028-06-30
Completion
2030-06-30
First posted
2025-03-07
Last updated
2025-03-07

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06863675. Inclusion in this directory is not an endorsement.